| | | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | |
|---|
|
| | | FI | PI | | Exelon Patch 5 | 30 Pflaster | 53.24 | 73.45 | 40% | | Transdermales Pflaster: Rivastigminum 9 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| | | FI | PI | | Exelon Patch 10 | 30 Pflaster | 53.24 | 73.45 | 40% | | Transdermales Pflaster: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| | | FI | PI | | Exelon Patch 10 | 60 Pflaster | 106.48 | 130.55 | 40% | | Transdermales Pflaster: Rivastigminum 18 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| | | FI | PI | | Exelon Patch 15 | 30 Pflaster | 53.24 | 73.45 | 40% | | Transdermales Pflaster: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| | | FI | PI | | Exelon Patch 15 | 60 Pflaster | 106.48 | 130.55 | 40% | | Transdermales Pflaster: Rivastigminum 27 mg | Novartis Pharma
Schweiz AG | B / SL / SO | FB | G |
| | | FI | PI | CM | Rivastigmin Patch Sandoz 5 | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | FI | PI | CM | Rivastigmin Patch Sandoz 10 | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | ● B / SL / SG | FB | G |
| | | FI | PI | CM | Rivastigmin Patch Sandoz 10 | 60 | 79.02 | 102.35 | 10% | | Transdermales Pflaster: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | FI | PI | CM | Rivastigmin Patch Sandoz 15 | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | FI | PI | CM | Rivastigmin Patch Sandoz 15 | 60 | 79.02 | 102.35 | 10% | | Transdermales Pflaster: Rivastigminum 27 mg | Sandoz
Pharmaceuticals AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin Zentiva Patch 4.6
mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 6.9 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 13.8 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin Zentiva Patch 9.5
mg/24 h | 2 x 30 | 79.02 | 102.35 | 10% | | Transdermales Pflaster: Rivastigminum 13.8 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermales Pflaster: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin Zentiva Patch
13.3 mg/24 h | 2 x 30 | 79.02 | 102.35 | 10% | | Transdermales Pflaster: Rivastigminum 19.2 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin-Mepha Patch 4.6
mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermale Pflaster: Rivastigminum 6.4 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin-Mepha Patch 9.5
mg/24 h | 2 x 30 | 79.02 | 102.35 | 10% | | Transdermale Pflaster: Rivastigminum 12.8 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 30 | 39.51 | 59.40 | 10% | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | ● B / SL / SG | FB | G |
| | | FI | PI | | Rivastigmin-Mepha Patch
13.3 mg/24 h | 2 x 30 | 79.02 | 102.35 | 10% | | Transdermale Pflaster: Rivastigminum 19.2 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | FI | PI | | Exelon 1,5 mg - T | 28 Kapsel(n) | 23.73 | 42.20 | 10% | | Kapseln: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 1,5 mg - T | 56 Kapsel(n) | 42.53 | 62.65 | 10% | | Kapseln: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 1,5 mg - T | 112 Kapsel(n) | 93.27 | 117.85 | 10% | | Kapseln: Rivastigminum 1.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 3 mg - T | 28 Kapsel(n) | 23.73 | 42.20 | 10% | | Kapseln: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 3 mg - T | 56 Kapsel(n) | 42.53 | 62.65 | 10% | | Kapseln: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 3 mg - T | 112 Kapsel(n) | 93.27 | 117.85 | 10% | | Kapseln: Rivastigminum 3 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 4,5 mg - T | 28 Kapsel(n) | 23.73 | 42.20 | 10% | | Kapseln: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 4,5 mg - T | 112 Kapsel(n) | 93.27 | 117.85 | 10% | | Kapseln: Rivastigminum 4.5 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 6 mg - T | 28 Kapsel(n) | 23.73 | 42.20 | 10% | | Kapseln: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 6 mg - T | 112 Kapsel(n) | 93.27 | 117.85 | 10% | | Kapseln: Rivastigminum 6 mg | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Exelon 2 mg/ml | 120 ml | 68.98 | 91.45 | 10% | | Lösung (oral): Rivastigminum 2 mg/ml | Novartis Pharma
Schweiz AG | B / SL | FB | G |
| | | FI | PI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 8 | | | k.A. | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B | FB | G |
| | | FI | PI | | Rivasur due volte alla
settimana 4,6 mg/24 ore | 16 | | | k.A. | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 25.92 mg | Zambon Svizzera SA | B | FB | G |
| | | FI | PI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 8 | | | k.A. | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B | FB | G |
| | | FI | PI | | Rivasur due volte alla
settimana 9,5 mg/24 ore | 16 | | | k.A. | | cerotto transdermico: (Cerotto Transdermico): Rivastigminum 51.84 mg | Zambon Svizzera SA | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 4,6
mg/24 h (9mg) | 30 | | | k.A. | | Transdermales Pflaster: Rivastigminum 9 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 30 | | | k.A. | | Transdermales Pflaster: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco 9,5
mg/24 h (18 mg) | 60 | | | k.A. | | Transdermales Pflaster: Rivastigminum 18 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 30 | | | k.A. | | Transdermales Pflaster: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
| | | | | | Rivastigmin Patch Sandoz eco
13,3 mg/24 h (23,1 mg) | 60 | | | k.A. | | Transdermales Pflaster: Rivastigminum 23.1 mg | Sandoz
Pharmaceuticals AG | B | FB | G |
